The published belrestotug/dostarlimab data is still too immature to prove the combination’s capability to disrupt the NSCLC ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Earlier this year, Nucala rolled out the Let’s Get to It campaign, which opts for an “unapologetically candid” tone, ...

AIG has appointed Keith Walsh as Executive Vice President and Chief Financial Officer, effective October 21. Walsh brings ...

Review the table below to see how GSK plc (ADR) stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions.

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

In the 24th year of the competition, Istanbul will stage its first-ever UEFA Women's Champions League tie this week as ...

Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...